Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC‐1 study design
Abstract Background Cancer cachexia is a multifactorial metabolic wasting syndrome characterized by anorexia, unintentional loss of weight involving both skeletal muscle and adipose tissues, progressive functional impairment and reduced survival. Therapeutic strategies for this serious condition are...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2024-06-01
|
| Reeks: | Journal of Cachexia, Sarcopenia and Muscle |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/jcsm.13435 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|